Report cover image

Digital Therapeutics Global Market Opportunities And Strategies To 2032 Including: 1) By Product: Software; Devices 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C) 3) By Application: Preventive Applications; Treatment Or Care

Publisher The Business Research Company
Published Jan 04, 2024
Length 256 Pages
SKU # BRC18402812

Description

Digital Therapeutics Global Market Opportunities And Strategies To 2032Including: 1) By Product: Software; Devices2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C) 3) By Application: Preventive Applications; Treatment Or Care-Related ApplicationsCovering: Teladoc Health Inc; Noom; Fitbit Health Solutions; Omada Health Inc; Biofourmis



Digital Therapeutics Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global digital therapeutics market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest growing market for digital therapeutics? How does the market relate to the overall economy, demography, and other similar markets? What forces will shape the market going forward? The digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider digital therapeutics market; and compares it with other markets.

The report covers the following chapters.
  • Introduction And Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the digital therapeutics market.
  • Key Trends
Highlights the major trends shaping the global digital therapeutics market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario
The report provides an analysis of the impact of the COVID-19 pandemic, the key effects of the Russia-Ukraine war in the region and worldwide and the impact of rising inflation on global and regional markets, providing strategic insights for businesses in the digital therapeutics market.
  • Global Market Size And Growth
Global historic (2017-2022) and forecast (2022-2027, 2032F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis
Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region.
  • Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by product, by sales channel and by application in the market. Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa, together with major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market share and company profiles of the leading players.
  • Key Mergers And Acquisitions
Information on recent mergers and acquisitions in the market covered by the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations
This section includes recommendations for digital therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currency codes used in this report

Scope

Markets Covered:

1) By Product: Software; Devices

2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)

3) By Application: Preventive Applications; Treatment Or Care-Related Applications

Companies Mentioned: Teladoc Health Inc.; Noom; Fitbit Health Solutions; Omada Health Inc.; Biofourmis

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; digital therapeutics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

256 Pages
1. Executive Summary
1.1. Digital Therapeutics – Market Attractiveness And Macro economic Landscape
2. Table Of Contents
3. List Of Tables
4. List Of Figures
5. Report Structure
6. Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Digital Therapeutics Market Definition And Segmentations
6.4. Market Segmentation By Product
6.4.1. Software
6.4.2. Devices
6.5. Market Segmentation By Sales Channel
6.5.1. Business-To-Business (B2B)
6.5.2. Business-To-Consumers (B2C)
6.6. Market Segmentation By Application
6.6.1. Preventive Applications
6.6.2. Treatment Or Care-Related Applications
7. Major Market Trends
7.1. Introduction Of Artificial Intelligence (AI) In Digital Therapeutics
7.2. Launch Of New Digital Therapeutics Platforms
7.3. Development Of Software For Accelerating Clinical Trials For Digital Therapeutics
7.4. Strategic Partnership and Collaborations Among Market Players
8. Digital Therapeutics Market - Macro Economic Scenario
8.1. COVID-19 Impact On The Digital Therapeutics Market
8.2. Russia-Ukraine War Impact On The Digital Therapeutics Market
8.3. Impact Of High Inflation On The Digital Therapeutics Market
9. Global Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
9.2.1. Market Drivers 2017 – 2022
9.2.2. Market Restraints 2017 – 2022
9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
9.3.1. Market Drivers 2022 – 2027
9.3.2. Market Restraints 2022 – 2027
10. Global Digital Therapeutics Market Segmentation
10.1. Global Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.3. Global Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11. Digital Therapeutics Market, Regional and Country Analysis
11.1. Global Digital Therapeutics Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11.2. Global Digital Therapeutics Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12. Asia-Pacific Market
12.1. Summary
12.1.1. Market Overview
12.1.2. Region Information
12.1.3. Market Information
12.1.4. Background Information
12.1.5. Government Initiatives
12.1.6. Regulations
12.1.7. Regulatory Bodies
12.1.8. Major Associations
12.1.9. Taxes Levied
12.1.10. Corporate Tax Structure
12.1.11. Investments
12.1.12. Major Companies
12.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.3. Asia-Pacific Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.4. Asia-Pacific Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.5. Asia-Pacific Digital Therapeutics Market: Country Analysis
12.6. China Market
12.7. Summary
12.7.1. Market Overview
12.7.2. Country Information
12.7.3. Market Information
12.7.4. Background Information
12.7.5. Government Initiatives
12.7.6. Regulations
12.7.7. Regulatory Bodies
12.7.8. Major Associations
12.7.9. Taxes Levied
12.7.10. Corporate Tax Structure
12.7.11. Investments
12.7.12. Major Companies
12.8. China Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.9. China Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.10. China Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.11. India Market
12.12. India Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.13. India Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.14. India Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.15. Japan Market
12.16. Japan Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.17. Japan Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.18. Japan Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.19. Australia Market
12.20. Australia Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.21. Australia Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.22. Australia Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.23. Indonesia Market
12.24. Indonesia Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.25. Indonesia Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.26. Indonesia Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.27. South Korea Market
12.28. South Korea Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.29. South Korea Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.30. South Korea Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13. Western Europe Market
13.1. Summary
13.1.1. Market Overview
13.1.2. Region Information
13.1.3. Market Information
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.3. Western Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.4. Western Europe Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.5. Western Europe Digital Therapeutics Market: Country Analysis
13.6. UK Market
13.7. UK Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.8. UK Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.9. UK Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.10. Germany Market
13.11. Germany Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.12. Germany Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.13. Germany Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.14. France Market
13.15. France Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.16. France Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.17. France Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14. Eastern Europe Market
14.1. Summary
14.1.1. Market Overview
14.1.2. Region Information
14.1.3. Market Information
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes Levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.3. Eastern Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.4. Eastern Europe Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.5. Eastern Europe Digital Therapeutics Market: Country Analysis
14.6. Russia Market
14.7. Russia Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.8. Russia Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.9. Russia Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15. North America Market
15.1. Summary
15.1.1. Market Overview
15.1.2. Region Information
15.1.3. Market Information
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Major Associations
15.1.9. Taxes Levied
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. North America Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.3. North America Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.4. North America Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.5. North America Digital Therapeutics Market: Country Analysis
15.6. USA Market
15.7. Summary
15.7.1. Market Overview
15.7.2. Country Information
15.7.3. Market Information
15.7.4. Background Information
15.7.5. Government Initiatives
15.7.6. Regulations
15.7.7. Regulatory Bodies
15.7.8. Major Associations
15.7.9. Taxes Levied
15.7.10. Corporate Tax Structure
15.7.11. Investments
15.7.12. Major Companies
15.8. USA Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.9. USA Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.10. USA Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16. South America Market
16.1. Summary
16.1.1. Market Overview
16.1.2. Region Information
16.1.3. Market Information
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Taxes Levied
16.1.10. Corporate Tax Structure
16.1.11. Investments
16.1.12. Major Companies
16.2. South America Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.3. South America Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.4. South America Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.5. South America Digital Therapeutics Market: Country Analysis
16.6. Brazil Market
16.7. Brazil Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.8. Brazil Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.9. Brazil Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17. Middle East Market
17.1. Summary
17.1.1. Market Overview
17.1.2. Region Information
17.1.3. Market Information
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. Middle East Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.3. Middle East Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.4. Middle East Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18. Africa Market
18.1. Summary
18.1.1. Market Overview
18.1.2. Region Information
18.1.3. Market Information
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Taxes Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Africa Digital Therapeutics Market, Segmentation By Product, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.3. Africa Digital Therapeutics Market, Segmentation By Sales Channel, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.4. Africa Digital Therapeutics Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
19. Competitive Landscape and Company Profiles
19.1. Company Profiles
19.2. Teladoc Health Inc.
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Noom
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Fitbit Health Solutions
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Omada Health Inc.
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
19.6. Biofourmis
19.6.1. Company Overview
19.6.2. Products And Services
19.6.3. Business Strategy
19.6.4. Financial Overview
20. Key Mergers And Acquisitions
20.1. HypnoVR Acquired Oncomfort
20.2. Sidekick Health Acquired Aidhere
20.3. Big Health Acquired Limbix
20.4. Pear Therapeutics Merged With Thimble Point Acquisition Corp.
21. Opportunities And Strategies To 2032
21.1. Global Digital Therapeutics Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Digital Therapeutics Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Digital Therapeutics Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Digital Therapeutics Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Geographies Covered
23.2. Market Data Sources
23.3. Research Methodology
23.4. Currencies
23.5. The Business Research Company
23.6. Copyright and Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us